INDIVIOR PLC Share Price Today: Live Updates & Key Insights

INDIVIOR PLC share price today is $28.7508, up -3.93%. The stock opened at $30.475 against the previous close of $30.5, with an intraday high of $30.475 and low of $28.65.

INDIVIOR PLC Share Price Chart

INDIVIOR PLC

us-stock
To Invest in {{usstockname}}
us-stock

INDIVIOR PLC Share Price Performance

$28.7508 -0.0393(-3.93%) INDV at 23 Mar 2026 01:39 PM Drug Manufacturers - Specialty & Generic
Lowest Today 28.65
Highest Today 30.475
Today’s Open 30.475
Prev. Close 30.5
52 Week High 38.00
52 Week Low 8.64
Day’s Range: Low 28.65 High 30.475
52-Week Range: Low 8.64 High 38.00
1 day return -
1 Week return -5.23
1 month return -10.99
3 month return -19.52
6 month return +25.95
1 year return +190.48
3 year return +31.73
5 year return -
10 year return -

INDIVIOR PLC Institutional Holdings

INDIVIOR PLC Market Status

Strong Buy: 5

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

INDIVIOR PLC Fundamentals

Market Cap 3664.41 M

PB Ratio 145.2492

PE Ratio 17.8659

Enterprise Value 3822.91 M

Total Assets 1204.00 M

Volume 6782267

INDIVIOR PLC Company Financials

Annual Revenue FY23:1042000000 1042.0M, FY22:901000000 901.0M, FY21:791000000 791.0M, FY20:647000000 647.0M, FY19:785000000 785.0M

Annual Profit FY23:863000000 863.0M, FY22:742000000 742.0M, FY21:664000000 664.0M, FY20:550000000 550.0M, FY19:645000000 645.0M

Annual Net worth FY23:-235000000 -235.0M, FY22:-53000000 -53.0M, FY21:205000000 205.0M, FY20:-148000000 -148.0M, FY19:134000000 134.0M

Quarterly Revenue Q3/2025:314000000 314.0M, Q2/2025:302000000 302.0M, Q1/2025:266000000 266.0M, Q3/2024:307000000 307.0M, Q2/2024:299607713 299.6M

Quarterly Profit Q3/2025:230000000 230.0M, Q2/2025:250000000 250.0M, Q1/2025:222000000 222.0M, Q3/2024:238000000 238.0M, Q2/2024:183371945 183.4M

Quarterly Net worth Q3/2025:42000000 42.0M, Q2/2025:18000000 18.0M, Q1/2025:47000000 47.0M, Q3/2024:4000000 4.0M, Q2/2024:-107217475 -107.2M

About INDIVIOR PLC & investment objective

Company Information Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. The company was formerly known as Indivior PLC. and changed its name to Indivior Pharmaceuticals, Inc. in January 2026. Indivior Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Organisation Drug Manufacturers - Specialty & Generic

Employees 827

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Joseph J. Ciaffoni

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

INDIVIOR PLC FAQs

What is the share price of INDIVIOR PLC today?

The current share price of INDIVIOR PLC is $28.7508.

Can I buy INDIVIOR PLC shares in India?

Yes, Indian investors can buy INDIVIOR PLC shares by opening an international trading and demat account with Motilal Oswal.

How to buy INDIVIOR PLC shares in India?

You can easily invest in INDIVIOR PLC shares from India by:

Can I buy fractional shares of INDIVIOR PLC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of INDIVIOR PLC?

INDIVIOR PLC has a market cap of $3664.41 M.

In which sector does INDIVIOR PLC belong?

INDIVIOR PLC operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in INDIVIOR PLC stocks?

To invest, you typically need:

What is the PE and PB ratio of INDIVIOR PLC?

The PE ratio of INDIVIOR PLC is 17.87 and the PB ratio is 145.25.